| Added by | liaudet-coopman |
|---|---|
| Group name | EquipeELC |
| Item Type | Journal Article |
| Title | Proteomic analysis of vascular smooth muscle cells in physiological condition and in pulmonary arterial hypertension: Toward contractile versus synthetic phenotypes |
| Creator | Régent et al. |
| Author | Alexis Régent |
| Author | Kim Heang Ly |
| Author | Sébastien Lofek |
| Author | Guilhem Clary |
| Author | Mathieu Tamby |
| Author | Nicolas Tamas |
| Author | Christian Federici |
| Author | Cédric Broussard |
| Author | Philippe Chafey |
| Author | Emmanuelle Liaudet-Coopman |
| Author | Marc Humbert |
| Author | Frédéric Perros |
| Author | Luc Mouthon |
| Abstract | Vascular smooth muscle cells (VSMCs) are highly specialized cells that regulate vascular tone and participate in vessel remodeling in physiological and pathological conditions. It is unclear why certain vascular pathologies involve one type of vessel and spare others. Our objective was to compare the proteomes of normal human VSMC from aorta (human aortic smooth muscle cells, HAoSMC), umbilical artery (human umbilical artery smooth muscle cells, HUASMC), pulmonary artery (HPASMC), or pulmonary artery VSMC from patients with pulmonary arterial hypertension (PAH-SMC). Proteomes of VSMC were compared by 2D DIGE and MS. Only 19 proteins were differentially expressed between HAoSMC and HPASMC while 132 and 124 were differentially expressed between HUASMC and HAoSMC or HPASMC, respectively (fold change 1.5? or -1.5?, p < 0.05). As much as 336 proteins were differentially expressed between HPASMC and PAH-SMC (fold change 1.5? or -1.5?, p < 0.05). HUASMC expressed increased amount of ?-smooth muscle actin compared to either HPASMC or HAoSMC (although not statistically significant). In addition, PAH-SMC expressed decreased amount of smooth muscle myosin heavy chain and proliferation rate was increased compared to HPASMC thus supporting that PAH-SMC have a more synthetic phenotype. Analysis with Ingenuity identified paxillin and (embryonic lethal, abnormal vision, drosophila) like 1 (ELAVL1) as molecules linked with a lot of proteins differentially expressed between HPASMC and PAH-SMC. There was a trend toward reduced proliferation of PAH-SMC with paxillin-si-RNA and increased proliferation with ELAVL1-siRNA. Thus, VSMCs have very diverse protein content depending on their origin and this is in link with phenotypic differentiation. Paxillin targeting may be a promising treatment of PAH. ELAVL1 also participate in the regulation of PAH-SMC proliferation. |
| Publication | Proteomics |
| Volume | 16 |
| Issue | 20 |
| Pages | 2637-2649 |
| Date | 10 2016 |
| Journal Abbr | Proteomics |
| Language | eng |
| DOI | 10.1002/pmic.201500006 |
| ISSN | 1615-9861 |
| Short Title | Proteomic analysis of vascular smooth muscle cells in physiological condition and in pulmonary arterial hypertension |
| Library Catalog | PubMed |
| Extra | PMID: 27458111 |
| Tags | Cell Proliferation, Cells, Cultured, ELAV-Like Protein 1, ELAVL1, Gene Expression Regulation, Humans, Hypertension, Pulmonary, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, original, Paxillin, Protein Interaction Maps, Proteome, Pulmonary Artery, Pulmonary hypertension, RNA Interference, RNA, Small Interfering, Vascular smooth muscle cell |
| Date Added | 2018/09/26 - 14:32:40 |
| Date Modified | 2019/05/29 - 12:25:04 |
Institut de Recherche en Cancérologie de
